Clorox (CLX) Misses Q1 EPS by 6c; Reaffirms Guidance

November 2, 2016 6:33 AM EDT

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

Clorox (NYSE: CLX) reported Q1 EPS of $1.36, $0.06 worse than the analyst estimate of $1.42. Revenue for the quarter came in at $1.44 billion versus the consensus estimate of $1.43 billion.


Clorox maintains sees FY2017 excluding ASU EPS of $5.13-$5.28, versus the consensus of $5.48.

"I'm very pleased about our solid start to the fiscal year, as investments behind our 2020 Strategy, including product innovation, resulted in continued strong topline growth," said Chairman and CEO Benno Dorer. "Notably, we grew volume in all U.S. and International segments. We also delivered these results on top of strong topline growth in the year-ago quarter."

"As we look to the remainder of the fiscal year, I feel good about the health of our core business and am confident in the strategic plans we have in place in the face of a challenging macro-economic environment," continued Dorer.

For earnings history and earnings-related data on Clorox (CLX) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance, Management Comments

Related Entities


Add Your Comment